Cargando…
Proton pump inhibitor usage associates with higher risk of first episodes of pneumonia and peritonitis in peritoneal dialysis patients
BACKGROUND: A large number of studies have shown that proton pump inhibitors (PPIs) are associated with infection events. Therefore, we retrospectively evaluated the association of PPI therapy with the occurrence of first pneumonia and peritoneal dialysis(PD)-related peritonitis events in the mainte...
Autores principales: | Zhang, Yujing, Li, Jiao, Chen, Zijun, Liu, Lingling, Zhan, Xiaojiang, Peng, Fenfen, Zhou, Qian, Wu, Xianfeng, Zeng, Yingsi, Zhu, Liya, Xie, Yuxin, Lai, Xiaochun, Wang, Zebin, Wen, Yueqiang, Feng, Xiaoran, Liang, Jianbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542879/ https://www.ncbi.nlm.nih.gov/pubmed/36195979 http://dx.doi.org/10.1080/0886022X.2022.2129064 |
Ejemplares similares
-
Proton pump inhibitor usage is associated with higher all-cause mortality and CV events in peritoneal dialysis patients
por: Zeng, Yingsi, et al.
Publicado: (2022) -
Hyperlipidemia and mortality in patients on peritoneal dialysis
por: Feng, Xiaoran, et al.
Publicado: (2022) -
Creatine Kinase and Mortality in Peritoneal Dialysis
por: Wu, Xianfeng, et al.
Publicado: (2022) -
Neutrophil to Lymphocyte Ratio Predicts Adverse Cardiovascular Outcome in Peritoneal Dialysis Patients Younger than 60 Years Old
por: Zeng, Yingsi, et al.
Publicado: (2020) -
Monocyte/Lymphocyte Ratio and Cardiovascular Disease Mortality in Peritoneal Dialysis Patients
por: Wen, Yueqiang, et al.
Publicado: (2020)